Already facing a possible delisting from NASDAQ, Exact Sciences Corp. reported more bad news.
Sales for the genomics firm slipped dramatically in 2008, pushing the company into the red for the year and offsetting cost-cutting moves made in July when it shed its R&D staff. Exact Sciences laid off eight employees, leaving a skeleton crew of four staff members at its Marlborough headquarters.